Home » EU Parliament Passes Pharmacovigilance Requirement to Report Adverse Reactions
EU Parliament Passes Pharmacovigilance Requirement to Report Adverse Reactions
October 14, 2010
Drugmakers and competent authorities would, for the first time, be required to report all adverse drug reactions — not just serious ones — to the EudraVigilance database, according to new pharmacovigilance legislation adopted Sept. 22 by the European Parliament.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor